研究者
J-GLOBAL ID：202001009540992308
更新日: 2024年02月13日
関 好孝
セキ ヨシタカ | Seki Yoshitaka
所属機関・部署：
職名：
外来研究員
競争的資金等の研究課題 (2件)：
- 2019 - 2023 肺がん患者の血漿中細胞外遊離DNA/RNAを用いた融合および耐性遺伝子の定量
- 2016 - 2018 肺がん患者の血漿中cell freeDNAを用いた融合および耐性遺伝子の定量
論文 (37件)：
-
Saori Takata, Kei Morikawa, Hisashi Tanaka, Hidetoshi Itani, Masashi Ishihara, Kazuya Horiuchi, Yasuhiro Kato, Shinnosuke Ikemura, Hideyuki Nakagawa, Yoshiro Nakahara, et al. Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study. Therapeutic advances in medical oncology. 2023. 15. 17588359231177021-17588359231177021
-
Kyota Shinfuku, Naoki Takasaka, Taiki Fukuda, Kentaro Chida, Yudai Suzuki, Shun Shibata, Ayako Kojima, Tsukasa Hasegawa, Masami Yamada, Yumie Yamanaka, et al. Association between serum ferritin level and decreased diffusion capacity 3 months after the onset of COVID-19 pneumonia. PloS one. 2023. 18. 2. e0281249
-
Yoshitaka Seki, Tatsuya Yoshida, Takashi Kohno, Ken Masuda, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Kazuyoshi Kuwano, Yuichiro Ohe. Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study. Respiratory investigation. 2022
-
Naoki Takasaka, Yusuke Hosaka, Taiki Fukuda, Kyota Shinfuku, Kentaro Chida, Shun Shibata, Ayako Kojima, Tsukasa Hasegawa, Masami Yamada, Yumie Yamanaka, et al. Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease. Respiratory medicine. 2022. 192. 106738-106738
-
Yudai Suzuki, Naoki Takasaka, Sachi Matsubayashi, Ayako Kojima, Kyota Shinfuku, Tsukasa Hasegawa, Masami Yamada, Ikumi Fujisaki, Aya Seki, Yoshitaka Seki, et al. Allergic bronchopulmonary aspergillosis in a patient with ankylosing spondylitis treated with adalimumab. Respirology case reports. 2021. 9. 8. e00805
もっと見る
MISC (21件)：
-
関 好孝, 藤原 豊, 河野 隆志, 後藤 悌, 堀之内 秀仁, 神田 慎太郎, 軒原 浩, 山本 昇, 桑野 和善, 大江 裕一郎. 血液中細胞外DNA(cfDNA)からのEGFR遺伝子変異検出が可能であった肺腺がん患者の臨床的背景. 肺癌. 2016. 56. 6. 550-550
-
Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Erina Takai, Kuniko Sunami, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Shun-ichi Watanabe, et al. Predominance of EGFR mutations responsible for resistance to tyrosine kinase inhibitors among tumor DNAs assessed by picoliter droplet digital PCR analysis of cell-free plasma DNAs. CANCER RESEARCH. 2015. 75
-
Yuki Katsuya, Hidehito Horinouchi, Tetsuhiko Asao, Shinsuke Kitahara, Kuniko Sunami, Yoshitaka Seki, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, et al. Programmed cell death 1 (PD-1) and its ligand (PD-L1) expression in thymic epithelial tumors (TETs): Impact on the treatment efficacy and alteration in expression after chemotherapy (C). JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 15
-
関 好孝, 藤原 豊, 神田 慎太郎, 堀之内 秀仁, 軒原 浩, 山本 昇, 田村 友秀, 河野 隆志. 細胞液浮遊液中の悪性細胞由来DNAの定量と悪性胸水由来DNAの濃縮への応用. 肺癌. 2014. 54. 5. 570-570
-
関 好孝, 藤原 豊, 神田 慎太郎, 堀之内 秀仁, 軒原 浩, 山本 昇, 大江 裕一郎, 荻原 秀明, 岩川 麗香, 河野 隆志. 進行肺非小細胞がん患者由来液性試料におけるCastPCRを用いたEGFR変異DNAの定量(CastPCR-based quantification of EGFR mutations in liquid biopsy samples from patients with non-small cell lung cancer). 日本癌学会総会記事. 2014. 73回. P-2378
もっと見る
所属学会 (4件)：
日本臨床腫瘍学会
, 日本肺癌学会
, 日本呼吸器学会
, 日本内科学会
